Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.

Yu J, Baron V, Mercola D, Mustelin T, Adamson ED.

Cell Death Differ. 2007 Mar;14(3):436-46. Epub 2006 Sep 22. Erratum in: Cell Death Differ. 2007 Mar;14(3):640.

2.

The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.

Baron V, Adamson ED, Calogero A, Ragona G, Mercola D.

Cancer Gene Ther. 2006 Feb;13(2):115-24. Review.

3.

Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53.

Krones-Herzig A, Mittal S, Yule K, Liang H, English C, Urcis R, Soni T, Adamson ED, Mercola D.

Cancer Res. 2005 Jun 15;65(12):5133-43.

4.

Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: evidence for an autoregulatory loop.

Pines A, Bivi N, Romanello M, Damante G, Kelley MR, Adamson ED, D'Andrea P, Quadrifoglio F, Moro L, Tell G.

Free Radic Res. 2005 Mar;39(3):269-81.

PMID:
15788231
5.

Co-factors p300 and CBP catch Egr1 in their network.

Adamson ED, Yu J, Mustelin T.

Prostate. 2005 Jun 1;63(4):407-10.

PMID:
15635605
6.
7.

Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy.

Zemljic-Harpf AE, Ponrartana S, Avalos RT, Jordan MC, Roos KP, Dalton ND, Phan VQ, Adamson ED, Ross RS.

Am J Pathol. 2004 Sep;165(3):1033-44.

8.
9.

Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility.

Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S, Hahn KM.

J Cell Biol. 2004 May 10;165(3):371-81.

10.

Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.

Parisi S, D'Andrea D, Lago CT, Adamson ED, Persico MG, Minchiotti G.

J Cell Biol. 2003 Oct 27;163(2):303-14.

11.

Insulin-like growth factor-II regulates PTEN expression in the mammary gland.

Moorehead RA, Hojilla CV, De Belle I, Wood GA, Fata JE, Adamson ED, Watson KL, Edwards DR, Khokha R.

J Biol Chem. 2003 Dec 12;278(50):50422-7. Epub 2003 Sep 29.

12.

In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target gene of Egr1.

De Belle I, Wu JX, Sperandio S, Mercola D, Adamson ED.

J Biol Chem. 2003 Apr 18;278(16):14306-12. Epub 2003 Jan 31.

13.

Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes.

Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D.

J Biol Chem. 2003 Apr 4;278(14):11802-10. Epub 2003 Jan 29.

14.

Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival.

Adamson ED, Mercola D.

Tumour Biol. 2002 Mar-Apr;23(2):93-102. Review.

PMID:
12065847
15.

Cripto: a tumor growth factor and more.

Adamson ED, Minchiotti G, Salomon DS.

J Cell Physiol. 2002 Mar;190(3):267-78. Review.

PMID:
11857442
16.

The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling.

Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, de Belle I.

Nat Cell Biol. 2001 Dec;3(12):1124-8.

PMID:
11781575
17.

Method for cloning in vivo targets of the Egr-1 transcription factor.

de Belle I, Mercola D, Adamson ED.

Biotechniques. 2000 Jul;29(1):162-9.

18.

Shigella actin-based motility in the presence of truncated vinculin.

Southwick FS, Adamson ED, Purich DL.

Cell Motil Cytoskeleton. 2000 Apr;45(4):272-8.

PMID:
10744860
19.

Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development.

Minchiotti G, Parisi S, Liguori G, Signore M, Lania G, Adamson ED, Lago CT, Persico MG.

Mech Dev. 2000 Feb;90(2):133-42.

20.

p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.

de Belle I, Huang RP, Fan Y, Liu C, Mercola D, Adamson ED.

Oncogene. 1999 Jun 17;18(24):3633-42.

21.
22.

Cripto: roles in mammary cell growth, survival, differentiation and transformation.

Niemeyer CC, Persico MG, Adamson ED.

Cell Death Differ. 1998 May;5(5):440-9.

23.

Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation.

Huang RP, Fan Y, deBelle I, Ni Z, Matheny W, Adamson ED.

Cell Death Differ. 1998 Jan;5(1):96-106.

24.
25.

Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2.

Huang RP, Fan Y, Peng A, Zeng ZL, Reed JC, Adamson ED, Boynton AL.

Int J Cancer. 1998 Sep 11;77(6):880-6.

26.

alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells.

Watabe-Uchida M, Uchida N, Imamura Y, Nagafuchi A, Fujimoto K, Uemura T, Vermeulen S, van Roy F, Adamson ED, Takeichi M.

J Cell Biol. 1998 Aug 10;142(3):847-57.

27.

Vinculin and cell-cell adhesion.

Tozeren A, Wu S, Hoxter B, Xu W, Adamson ED, Byers SW.

Cell Adhes Commun. 1998 Jan;5(1):49-59.

PMID:
9638341
29.

Specific arrest of cardiogenesis in cultured embryonic stem cells lacking Cripto-1.

Xu C, Liguori G, Adamson ED, Persico MG.

Dev Biol. 1998 Apr 15;196(2):237-47.

30.

Differences in elasticity of vinculin-deficient F9 cells measured by magnetometry and atomic force microscopy.

Goldmann WH, Galneder R, Ludwig M, Xu W, Adamson ED, Wang N, Ezzell RM.

Exp Cell Res. 1998 Mar 15;239(2):235-42.

PMID:
9521841
31.

Vinculin knockout results in heart and brain defects during embryonic development.

Xu W, Baribault H, Adamson ED.

Development. 1998 Jan;125(2):327-37.

32.

Reciprocal modulation between Sp1 and Egr-1.

Huang RP, Fan Y, Ni Z, Mercola D, Adamson ED.

J Cell Biochem. 1997 Sep 15;66(4):489-99.

PMID:
9282327
33.

Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation.

Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED.

Int J Cancer. 1997 Jul 3;72(1):102-9.

34.

Expression and function of amphiregulin during murine preimplantation development.

Tsark EC, Adamson ED, Withers GE 3rd, Wiley LM.

Mol Reprod Dev. 1997 Jul;47(3):271-83.

PMID:
9170107
35.

[Targeting the gene for platelet-derived growth factor A-chain (PDGF-A) and preparation of chimeric mice with a "knockout" genome].

Makarova IV, Neznanov NS, Tsymbaliuk ES, Andreeva LE, Manuilova ES, Grivennikov IA, Tarantul VZ, Serov SM, Adamson ED, Gazarian KG.

Mol Gen Mikrobiol Virusol. 1997;(4):23-5. Russian.

PMID:
9411216
36.

The EGFR gene family in embryonic cell activities.

Adamson ED, Wiley LM.

Curr Top Dev Biol. 1997;35:71-120. Review. No abstract available.

PMID:
9292268
37.

Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines.

Calogero A, Cuomo L, D'Onofrio M, de Grazia U, Spinsanti P, Mercola D, Faggioni A, Frati L, Adamson ED, Ragona G.

Oncogene. 1996 Nov 21;13(10):2105-12.

PMID:
8950977
39.

RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells.

Horn V, Minucci S, Ogryzko VV, Adamson ED, Howard BH, Levin AA, Ozato K.

FASEB J. 1996 Jul;10(9):1071-7.

PMID:
8801169
40.

UV activates growth factor receptors via reactive oxygen intermediates.

Huang RP, Wu JX, Fan Y, Adamson ED.

J Cell Biol. 1996 Apr;133(1):211-20.

41.

Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1.

Cui MZ, Parry GC, Oeth P, Larson H, Smith M, Huang RP, Adamson ED, Mackman N.

J Biol Chem. 1996 Feb 2;271(5):2731-9.

42.

Vinculin, talin and focal adhesions.

Goldmann WH, Ezzell RM, Adamson ED, Niggli V, Isenberg G.

J Muscle Res Cell Motil. 1996 Feb;17(1):1-5. Review. No abstract available.

PMID:
8740427
43.

Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.

Huang RP, Liu C, Fan Y, Mercola D, Adamson ED.

Cancer Res. 1995 Nov 1;55(21):5054-62.

44.

Epidermal growth factor receptor function in early mammalian development.

Wiley LM, Adamson ED, Tsark EC.

Bioessays. 1995 Oct;17(10):839-46. Review.

PMID:
7487966
45.

Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotion.

Coll JL, Ben-Ze'ev A, Ezzell RM, Rodríguez Fernández JL, Baribault H, Oshima RG, Adamson ED.

Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9161-5.

46.

The expression of megalin (gp330) and LRP diverges during F9 cell differentiation.

Czekay RP, Orlando RA, Woodward L, Adamson ED, Farquhar MG.

J Cell Sci. 1995 Apr;108 ( Pt 4):1433-41.

47.

A biological role for Egr-1 in cell survival following ultra-violet irradiation.

Huang RP, Adamson ED.

Oncogene. 1995 Feb 2;10(3):467-75.

PMID:
7845671
48.

V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras.

Huang RP, Ngo L, Okamura D, Tucker M, Adamson ED.

J Cell Biochem. 1994 Dec;56(4):469-79.

PMID:
7890805
49.

The phosphorylated forms of the transcription factor, Egr-1, bind to DNA more efficiently than non-phosphorylated.

Huang RP, Adamson ED.

Biochem Biophys Res Commun. 1994 May 16;200(3):1271-6.

PMID:
8185575
50.

Suppression of v-sis-dependent transformation by the transcription factor, Egr-1.

Huang RP, Darland T, Okamura D, Mercola D, Adamson ED.

Oncogene. 1994 May;9(5):1367-77.

PMID:
8152797

Supplemental Content

Loading ...
Support Center